Key facts
- This page summarizes Erin Ator Thomson's Form 4 filing for Shattuck Labs, Inc. (STTK).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 27 Jan 2023, 17:11.
Erin Ator Thomson - 25 Jan 2023 Form 4 Insider Report for Shattuck Labs, Inc. (STTK)
- Reporting relationship
- General Counsel
- Issuer ticker
- STTK
- Reported as of
- 25 Jan 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 27 Jan 2023, 17:11:41 UTC
- Prior SEC filing
- 12 Jan 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Erin Ator Thomson
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Erin Ator Thomson filed Form 4 for Shattuck Labs, Inc. (STTK) on 27 Jan 2023.
Change
- Previous filing in this sequence was filed on 12 Jan 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
STTK
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +24,125
- Change %
- +31%
- Price
- $0.000000
- Shares after
- 103,209
- Date
- 25 Jan 2023
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
STTK
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +48,250
- Change %
- Price
- $0.000000
- Shares after
- 48,250
- Date
- 25 Jan 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 48,250
- Exercise price
- $3.57
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Consists of 24,125 restricted stock units, which will vest in four equal annual installments beginning on January 25, 2024, subject to the Reporting Person's continued service to the Issuer.
Footnote F2
This option represents a right to purchase a total of 48,250 shares of the Issuer's common stock, one quarter of which will vest on January 25, 2024, with the remaining three quarters vesting in equal monthly installments through January 25, 2027, subject to the Reporting Person's continued service to the Issuer.